Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  MELK inhibitor OTS167
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Phase 1 Study of OTS167 in Patients With Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: OTS167-FR02, NCI-2015-02288, NCT01910545
Start Over